Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Global | Publication | June 3, 2016
Welcome to Essential Corporate News, our weekly news service covering the latest developments in the UK corporate world.
On May 30, 2016 the European Securities and Markets Authority (ESMA) published a new Q&A, which provides responses to questions posed by the general public and competent authorities in relation to the practical application of the Market Abuse Regulation (MAR) framework. The Q&A is aimed at competent authorities to ensure that their supervisory activities and their actions are converging along the lines of the responses adopted by ESMA and at helping issuers, investors and other market participants by providing clarity on the content of the market abuse rules.
The Q&A currently includes one question which clarifies the scope of firms subject to the provision in Article 16(2) of MAR requiring them to detect and report suspicious orders and transactions. ESMA confirms that this requirement applies broadly and “persons professionally arranging or executing transactions” will include buy side firms such as UCITS management companies, alternative investment fund managers (AIFMs) and firms professionally engaged in trading on own account.
The Q&A will be updated where relevant as and when new questions or issues arise.
(ESMA, Q&A on the Market Abuse Regulation (ESMA/2016/738), 30.05.16)
On May 31, 2016, the European Commission published additional non-binding Q&A on the implementation of the new statutory audit framework which will apply from June 17, 2016. These Q&A are in addition to those published in September 2014 and February 2016.
The Q&A discuss the following:
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023